You have 9 free searches left this month | for more free features.

fotemustine

Showing 1 - 6 of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Malignant Melanoma, Recurrent Melanoma Trial (Dacarbazine, Fotemustine, Interferon Alfa-2b)

Completed
  • Malignant Melanoma
  • Recurrent Melanoma
  • (no location specified)
Oct 18, 2020

Malignant Melanoma Trial in Italy (bevacizumab [Avastin], fotemustine)

Completed
  • Malignant Melanoma
  • bevacizumab [Avastin]
  • fotemustine
  • Firenze, Italy
  • +3 more
Nov 7, 2018

Glioblastoma Multiforme Trial in Italy (bevacizumab [Avastin], fotemustine)

Completed
  • Glioblastoma Multiforme
  • bevacizumab [Avastin]
  • fotemustine
  • Napoli, Campania, Italy
  • +9 more
Feb 16, 2016

Brain Metastases Trial in Italy (Fotemustine, Fotemustine and Ipilimumab, Ipilimumab and nivolumab)

Unknown status
  • Brain Metastases
  • Fotemustine
  • +2 more
  • Bari, Italy
  • +10 more
Jun 1, 2015

Intraocular Melanoma, Metastatic Cancer Trial in Worldwide (fotemustine, isolated perfusion)

Terminated
  • Intraocular Melanoma
  • Metastatic Cancer
  • fotemustine
  • isolated perfusion
  • Milan, Italy
  • +7 more
Sep 20, 2012

Melanoma (Skin) Trial in Montpellier (fotemustine, gene expression analysis, polymerase chain reaction)

Completed
  • Melanoma (Skin)
  • fotemustine
  • +2 more
  • Montpellier, France
    Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
May 13, 2011